BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17419378)

  • 1. [Role of mediators in the onset of COPD].
    Takizawa H
    Nihon Rinsho; 2007 Apr; 65(4):623-7. PubMed ID: 17419378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neutrophils and macrophages related to the pathogenesis and disease development of chronic obstructive pulmonary disease by the inflammatory reaction].
    Ohbayashi O; Takizawa H
    Nihon Rinsho; 2011 Oct; 69(10):1741-7. PubMed ID: 22073566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of inflammatory cells in the development of airway inflammation].
    Takizawa H
    Nihon Rinsho; 2003 Dec; 61(12):2107-12. PubMed ID: 14674318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mediators of chronic obstructive pulmonary disease.
    Barnes PJ
    Pharmacol Rev; 2004 Dec; 56(4):515-48. PubMed ID: 15602009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway inflammation in chronic obstructive pulmonary disease.
    Górska K; Maskey-Warzechowska M; Krenke R
    Curr Opin Pulm Med; 2010 Mar; 16(2):89-96. PubMed ID: 19904205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small airways: an important but neglected target in the treatment of obstructive airway diseases.
    Sturton G; Persson C; Barnes PJ
    Trends Pharmacol Sci; 2008 Jul; 29(7):340-5. PubMed ID: 18514920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease.
    Barczyk A; Pierzchała W; Kon OM; Cosio B; Adcock IM; Barnes PJ
    J Allergy Clin Immunol; 2006 Jun; 117(6):1484-92. PubMed ID: 16751017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of COPD.
    Spurzem JR; Rennard SI
    Semin Respir Crit Care Med; 2005 Apr; 26(2):142-53. PubMed ID: 16088433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2.
    Traves SL; Smith SJ; Barnes PJ; Donnelly LE
    J Leukoc Biol; 2004 Aug; 76(2):441-50. PubMed ID: 15155777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cells, mediators and Toll-like receptors in COPD.
    Sarir H; Henricks PA; van Houwelingen AH; Nijkamp FP; Folkerts G
    Eur J Pharmacol; 2008 May; 585(2-3):346-53. PubMed ID: 18410916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview.
    Di Stefano A; Caramori G; Ricciardolo FL; Capelli A; Adcock IM; Donner CF
    Clin Exp Allergy; 2004 Aug; 34(8):1156-67. PubMed ID: 15298554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory markers in COPD.
    Larsson K
    Clin Respir J; 2008 Oct; 2 Suppl 1():84-7. PubMed ID: 20298355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
    Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of COPD. Part III. Inflammation in COPD.
    Roth M
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):375-80. PubMed ID: 18371261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytokine network in chronic obstructive pulmonary disease.
    Barnes PJ
    Am J Respir Cell Mol Biol; 2009 Dec; 41(6):631-8. PubMed ID: 19717810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease.
    McNamara PS; Smyth RL
    Drug News Perspect; 2005 Dec; 18(10):615-21. PubMed ID: 16491163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killer cells in chronic obstructive pulmonary disease.
    Fairclough L; Urbanowicz RA; Corne J; Lamb JR
    Clin Sci (Lond); 2008 Apr; 114(8):533-41. PubMed ID: 18336369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease.
    Jeffery PK
    Novartis Found Symp; 2001; 234():149-61; discussion 161-8. PubMed ID: 11199094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
    Brozyna S; Ahern J; Hodge G; Nairn J; Holmes M; Reynolds PN; Hodge S
    COPD; 2009 Feb; 6(1):4-16. PubMed ID: 19229703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytokines and proteases involved in pathogenesis of COPD].
    Yamaya A; Osanai K
    Nihon Rinsho; 2011 Oct; 69(10):1748-53. PubMed ID: 22073567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.